Join the Fluarix group to help and get support from people like you.
Fluarix News (Page 2)
COVID-19, Flu, RSV Vaccine Coverage Low for Adults in 2024 to 2025 Season
MONDAY, Nov. 25, 2024 – COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025), according to research...
Flu, COVID Vaccination Rates Remain Low as Winter Nears
FRIDAY, Nov. 22, 2024 – Worn down by pandemic-era vaccine overload, many Americans are ignoring pleas by health officials to get immunized against the flu and COVID-19, new data shows. According to...
Reactogenicity Comparable for Simultaneous, Sequential COVID-19, Flu Shots
FRIDAY, Nov. 8, 2024 – Reactogenicity is comparable for simultaneous and sequential administration of mRNA COVID-19 and influenza vaccines, according to a study published online Nov. 6 in JAMA...
Flu Vaccine Coverage 80.7 Percent for Health Workers in Acute Care Hospitals
FRIDAY, Nov. 1, 2024 – Influenza and 2023 to 2024 COVID-19 vaccination coverage is 80.7 and 15.3 percent, respectively, among health care personnel at acute care hospitals and is lower among health...
Flu-Linked Hospitalization Rates Vary Across Seasons, Highest in Adults 65+
WEDNESDAY, Oct. 30 2024 – Influenza-associated hospitalization rates vary across seasons, and only returned to recent pre-COVID-19 pandemic levels in the 2022-2023 influenza season, according to...
IDSA: Vaccination Less Likely With Increasing Social Vulnerability, Black Race
FRIDAY, Oct. 18, 2024 – Vaccination for influenza, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and respiratory syncytial virus (RSV) is less likely with an increasing social...
The Right Time is Now to Get Your Flu Vaccine
THURSDAY, Oct. 17, 2024 – Folks who want solid protection during the cold and flu season should get the influenza vaccine now, the U.S. Food and Drug Administration says. The ideal time to get the...
Letter Nudges Increase Likelihood of Flu Vaccination for Adults With Chronic Diseases
FRIDAY, Oct. 11, 2024 – For patients aged 18 to 64 years with chronic diseases, electronically delivered letter nudges increase influenza vaccination rates compared with usual care, according to a...
This Season's Flu Vaccine Cuts Risk of Hospitalization by Almost 35%
THURSDAY, Oct. 3, 2024, HealthDay News – The Southern Hemisphere's flu season is winding down, and new data shows this year's flu shot was 34.5% effective in keeping folks there who got influenza...
FDA Approves First Flu Vaccine That Can Be Self-Administered at Home
FRIDAY, Sept. 20, 2024 – On Friday, the U.S. Food and Drug Administration approved the FluMist nasal vaccine for self-administration at home. It is a "new option for receiving a safe and effective...
Universal Flu Vaccine Blocks Infection in Mice
THURSDAY, Aug. 22, 2024 – A universal flu vaccine that would protect against all influenza strains – and that people might not need to take every year – could be close at hand, researchers report....
CureVac’s Coronavirus Vaccine at the Center of a Fight for Control
CureVac, a German biopharmaceutical company, has hit the headlines after US President Trump tried to secure exclusive rights to its developmental coronavirus vaccine. The vaccine is being developed...
FDA Approves GlaxoSmithKline's Fluarix Quadrivalent - Four-strain Seasonal Influenza Vaccine for Use in the U.S.
LONDON, Dec. 17, 2012 /PRNewswire/ -- GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the U.S. Food and Drug Administration (FDA) has approved FLUARIX® QUADRIVALENT (Influenza Virus V...
FDA Approves Seasonal Influenza Vaccine Fluarix for Pediatric Use
SILVER SPRING, Md., Oct. 19 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved use of the seasonal influenza vaccine Fluarix for children ages 3 years to 17 years....